High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure: A Prospective Cohort Study.

Saudi J Med Med Sci · 2021 · PMC8474003 · PMID 34667467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The cohort of patients that failed HFNC therapy had a higher prevalence of comorbidities (i.e., diabetes, hypertension, chronic kidney disease and asthma), but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.